Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Multiple Myeloma"
language:"English"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Multiple+Myeloma%22&filter%5B%5D=language%3A%22English%22&lookfor=%22Myeloma%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Multiple+Myeloma%22&filter%5B%5D=language%3A%22English%22&lookfor=%22Myeloma%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Multiple+Myeloma%22&filter%5B%5D=language%3A%22English%22&lookfor=%22Myeloma%22&type=Subject
PubPharm (7.390)
1
Laboratory reflex testing strategy for the early identification of primary care patients with multiple myeloma
enthalten in:
Clinical biochemistry
| 2024
von
Salinas, M.
|
Flores, E.
|
Blasco, A.
| +6
Wird geladen...
2
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols : Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Melphalan Hydrochloride in Treating Participants With Newly-Diagnosed Multiple Myeloma Undergoing Donor Stem Cell Transplantation : Prospective Phase I/II Trial to Jointly Optimize the Administration Schedule(s) and Dose(s) of Melphalan for Injection (Evomela) as a Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Study of ATLCAR.CD138 Cells for Relapsed/Refractory Multiple Myeloma : Phase I Study of Autologous CAR T-Cells Targeting the CD138 Antigen for Relapsed or Refractory Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients : A Single Arm, Response-adapted, Open Label Study of Iberdomide, Weekly Bortezomib and Dexamethasone (IberBd) With Isatuximab Added on Demand for Transplant-ineligible, Newly Diagnosed Multiple Myeloma Patients: the BOREALIS Trial
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Phase 2 Study Applying MRD Techniques for Participants With Previously Untreated Multiple Myeloma Treated With D-VRd Prior To and After High-dose Therapy Followed by ASCT - TAURUS : Phase 2 Study Applying Innovative Minimal Residual Disease (MRD) Techniques for Participants With Previously Untreated Multiple Myeloma Treated With D-VRd Prior To and After High-dose Therapy Followed by Autologous Stem Cell Transplantation (ASCT) - TAURUS
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
An Clinical Study of NKG2D-CAR-NK Cells for the Treatment of Refractory Recurrent Multiple Myeloma : An Exploratory Clinical Study of the Safety and Efficacy of NKG2D Chimeric Antigen Receptor NK Cell Injections for the Treatment of Efractory Recurrent Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) : Molecular Analysis for Therapy Choice (MATCH)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
A Study to Determine Dose, Safety, Tolerability, Drug Levels, and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Participants With Multiple Myeloma : A Phase 1b/2a Multicenter, Open-label, Dose-escalation Study to Determine the Maximum Tolerated Dose, Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CC-220 as Monotherapy and in Combination With Other Treatments in Subjects With Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation : A Randomized Phase II Study to Compare the Net Clinical Benefit of Cyclosporine and Sirolimus Combined With MMF or Post-Transplant Cyclophosphamide as GVHD Prophylaxis After HLA-Matched or HLA-Mismatched Unrelated G-CSF Mobilized Blood Cell Transplantation Using Nonmyeloablative or Reduced Intensity Conditioning for Patients With Hematologic Malignancies
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[739]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Multiple Myeloma
Filter aufheben
Sprache: Englisch
Medienart
7.348
Aufsätze
6.072
E-Ressourcen
6.049
E-Artikel
1.299
Gedruckte Aufsätze
42
Bücher
23
E-Books
19
Gedruckte Bücher
Alle anzeigen ...
weniger ...
Zeitschriftentitel
3.159
ClinicalTrials.gov
1.401
Reactions weekly
800
Inpharma weekly
269
Annals of hematology
175
PharmacoEconomics & outcomes news
88
International journal of hematology
63
Drugs
49
Inpharma
43
BMC cancer
36
Current treatment options in oncology
30
Current hematologic malignancy reports
27
Journal of cancer research and clinical oncology
26
Journal of medical case reports
22
Cancer chemotherapy and pharmacology
21
Digestive diseases and sciences
20
Journal for ImmunoTherapy of Cancer
19
PharmacoEconomics
18
Drugs & aging
17
European journal of nuclear medicine and molecu...
17
Journal of hematology & oncology
Alle anzeigen ...
weniger ...
Thema
Multiple Myeloma
3.159
610
2.704
Study Type: Interventional
2.644
Neoplasms, Plasma Cell
1.336
Myeloma
1.194
Recruitment Status: Completed
955
Phase: Phase 2
791
Medical Condition: Multiple Myeloma
720
Recruitment Status: Recruiting
703
Bortezomib
657
Phase: Phase 1
587
Thalidomide
494
Dexamethasone
465
Lymphoma
440
Recruitment Status: Active, not recruiting
418
Study Type: Observational
367
Recruitment Status: Terminated
325
Zoledronic Acid
324
Leukemia
311
Melphalan
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2.163
2020-
2.480
2010-2019
1.535
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
Englisch
3
Russisch
3
Ukrainisch
2
Portugiesisch
2
Spanisch
1
Polnisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...